Oncogenic CUL4A determines the response to thalidomide treatment in prostate cancer

Thalidomide is experimentally used to treat various human cancers; however, clinical responses to thalidomide are sporadic. Here we demonstrate that CUL4A plays an oncogenic role in prostate cancer development and prostate cancer cells with higher level of CUL4A are particularly sensitive to thalido...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ren, Shancheng, Xu, Chuanliang, Cui, Zilian, Yu, Yongwei, Xu, Weidong, Wang, Fubo, Lu, Ji, Wei, Min, Lu, Xin, Gao, Xu, Liang, You, Mao, Jian-Hua, Sun, Yinghao
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3650856/
https://ncbi.nlm.nih.gov/pubmed/22422151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00109-012-0885-0
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak